The following information is missing from the Funding section: MB received funding from the National Alopecia Areata Foundation (USA) and Associazione Mediterranea Alopecia Areata (Italy).
Reference
- 1. Hamed FN, Åstrand A, Bertolini M, Rossi A, Maleki-Dizaji A, Messenger AG, et al. (2019) Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease. PLoS ONE 14(7): e0210308. https://doi.org/10.1371/journal.pone.0210308 pmid:31277078
Citation: Hamed FN, Åstrand A, Bertolini M, Rossi A, Maleki-Dizaji A, Messenger AG, et al. (2019) Correction: Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease. PLoS ONE 14(9): e0222473. https://doi.org/10.1371/journal.pone.0222473
Published: September 9, 2019
Copyright: © 2019 Hamed et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.